2m 2m 2m 2m 2m 2m 2m
Humana (HUM)
NYSE
$359.56-$1.17 (-0.32%)
Price as of Jun 23, 2026 5:03 PM EDT- $43.3BMarket Cap
- 56.15%1-Year Change
- Healthcare PlansIndustry
Humana (HUM)
$359.56-$1.17 (-0.32%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 129.7B +10.11% | 117.8B +10.70% | 106.4B +14.54% | 92.9B +11.81% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 129.7B +10.11% | 117.8B +10.70% | 106.4B +14.54% | 92.9B +11.81% | |
Sales and Marketing Expense | 15.4B +12.81% | 13.7B +3.85% | 13.2B +4.08% | 12.7B +25.20% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 773.0M -14.87% | 908.0M +6.82% | 850.0M +13.48% | 749.0M +17.03% | |
Total Operating Expenses | 127.0B +10.21% | 115.2B +12.54% | 102.4B +14.92% | 89.1B +11.45% | |
Operating Profit | 2.7B +5.54% | 2.6B -36.16% | 4.0B +5.61% | 3.8B +20.71% | |
Interest Income | 1.0B -17.94% | 1.2B +14.69% | 1.1B +179.84% | 382.0M +104.28% | |
Interest Expense | N/A N/A | N/A N/A | -493.0M +22.94% | -401.0M +23.01% | |
Interest Income and Expense and Net | 1.0B -17.94% | 1.2B +112.85% | 576.0M +3,131.58% | -19.0M -86.33% | |
Total Nonoperating Income and Expense | -451.0M +149.17% | -181.0M +32.12% | -137.0M +101.47% | -68.0M -112.78% | |
Income before Taxes | 1.6B -9.65% | 1.7B -49.13% | 3.4B -5.18% | 3.6B +6.38% | |
Income Taxes | 250.0M -39.47% | 413.0M -50.60% | 836.0M +9.71% | 762.0M +57.11% | |
Extraordinary Items | 253.0M +178.02% | 91.0M 0.00% | 91.0M N/A | N/A N/A | |
Net Income | 1.2B -1.57% | 1.2B -51.51% | 2.5B -11.30% | 2.8B -4.33% | |
Net Income from Continuing Operations Applicable to Common | 1.2B -1.57% | 1.2B -51.51% | 2.5B -11.30% | 2.8B -4.33% | |
Basic EPS and Net Income | 9.87 -1.40% | 10.01 -50.17% | 20.09 -9.50% | 22.20 -2.59% | |
Diluted EPS and Net Income | 9.84 -1.40% | 9.98 -50.10% | 20.00 -9.42% | 22.08 -2.60% | |
Basic Weighted Average Shares | 120.5M -0.10% | 120.6M -2.66% | 123.9M -2.02% | 126.4M -1.76% | |
Diluted Weighted Average Shares | 120.8M -0.04% | 120.9M -2.87% | 124.4M -2.09% | 127.1M -1.78% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.2B +89.10% | 2.2B -52.68% | 4.7B -7.25% | 5.1B +49.12% | |
Short-Term Investments | 15.7B -13.79% | 18.2B +9.55% | 16.6B +19.78% | 13.9B +5.22% | |
Cash and Cash Equivalents and Short-Term Investments | 19.9B -2.60% | 20.4B -4.15% | 21.3B +12.55% | 18.9B +14.20% | |
Total Current Assets | 32.7B +9.79% | 29.8B -0.57% | 30.0B +14.52% | 26.2B +5.18% | |
Accumulated Depreciation | 3.3B +4.75% | 3.1B +9.99% | 2.9B -8.99% | 3.1B +9.12% | |
Property and Plant and Equipment and Net | 2.2B -11.89% | 2.5B -16.44% | 3.0B -5.93% | 3.2B +4.82% | |
Total Long-Term Assets | 3.1B -7.54% | 3.4B +0.18% | 3.4B -0.09% | 3.4B -22.81% | |
Total Assets | 48.9B +5.23% | 46.5B -1.25% | 47.1B +9.31% | 43.1B -2.94% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 577.0M -60.01% | 1.4B -31.02% | 2.1B +7.12% | |
Total Current Liabilities | 16.3B -3.50% | 16.9B -10.24% | 18.9B +9.86% | 17.2B +12.05% | |
Total Long-Term Debt | 12.4B +10.99% | 11.1B +9.12% | 10.2B +13.05% | 9.0B -14.30% | |
Total Long-Term Liabilities | 2.5B +25.94% | 2.0B +17.39% | 1.7B +12.83% | 1.5B -38.19% | |
Total Liabilities | 31.2B +3.79% | 30.0B -2.32% | 30.7B +11.06% | 27.7B -2.02% | |
Retained Earnings | 29.1B +2.68% | 28.3B +2.82% | 27.5B +8.03% | 25.5B +10.42% | |
Total Stockholders Equity | 17.7B +7.83% | 16.4B +0.69% | 16.3B +6.21% | 15.3B -4.92% | |
Total Shares Outstanding | 198.7M +0.0003% | 198.7M +0.01% | 198.7M +0.01% | 198.7M +0.009% | |
Cash Flow | |||||
Cash from Operating Activities | 921.0M -68.95% | 3.0B -25.50% | 4.0B -13.21% | 4.6B +102.79% | |
Capital Expenditures | 546.0M -5.04% | 575.0M -42.73% | 1.0B -10.36% | 1.1B -14.89% | |
Cash from Investing Activities | 2.3B +177.00% | -3.0B -15.46% | -3.5B +247.12% | -1.0B -84.66% | |
Dividends Paid | 430.0M -0.23% | 431.0M 0.00% | 431.0M +9.95% | 392.0M +10.73% | |
Cash from Financing Activities | -1.2B -51.15% | -2.5B +190.54% | -856.0M -55.28% | -1.9B -163.48% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 2.09% -4.15% | 2.18% -42.33% | 3.77% -7.80% | 4.09% +7.97% | |
Return on Assets | 2.49% -3.48% | 2.58% -53.28% | 5.52% -13.96% | 6.42% -13.18% | |
Return on Equity | 6.98% -5.61% | 7.40% -53.09% | 15.77% -11.74% | 17.86% -9.15% | |
Revenue Growth | 10.11% -5.58% | 10.70% -26.38% | 14.54% +23.17% | 11.81% +54.15% | |
Current Ratio | 2.00 +13.77% | 1.76 +10.77% | 1.59 +4.24% | 1.52 -6.13% | |
Cash Ratio | 0.26 +95.96% | 0.13 -47.29% | 0.25 -15.58% | 0.29 +33.06% | |
Debt-to-Equity Ratio | 0.70 -2.14% | 0.72 -0.14% | 0.72 -1.36% | 0.73 -6.34% | |
Debt-to-Assets Ratio | 0.25 +0.28% | 0.25 +1.82% | 0.25 -4.14% | 0.26 -8.27% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow